{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:57:06Z","timestamp":1792796226070,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113861","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T04:26:21Z","timestamp":1632457581000},"page":"113861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthesis and evaluation of tetrahydroisoquinoline derivatives against Trypanosoma brucei rhodesiense"],"prefix":"10.1016","volume":"226","author":[{"given":"Danica R.","family":"Cullen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-357X","authenticated-orcid":false,"given":"Ashlee","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-6857","authenticated-orcid":false,"given":"Caitlin L.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutharat","family":"Pengon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roonglawan","family":"Rattanajak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6136-7795","authenticated-orcid":false,"given":"Jason","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3897-1948","authenticated-orcid":false,"given":"Hendra","family":"Gunosewoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumalee","family":"Kamchonwongpaisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-7846","authenticated-orcid":false,"given":"Mauro","family":"Mocerino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113861_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human african trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113861_bib2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1469-0691.2011.03536.x","article-title":"Sleeping sickness","volume":"17","author":"Malvy","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2021.113861_bib3","series-title":"Working to Overcome the Global Impact of Neglected Tropical Diseases: First WHO Report on Neglected Tropical Diseases","year":"2010"},{"key":"10.1016\/j.ejmech.2021.113861_bib4","series-title":"Control and Surveillance of Human African Trypanosomiasis: Report of a WHO Expert Committee","year":"2013"},{"key":"10.1016\/j.ejmech.2021.113861_bib5","first-page":"257","article-title":"Epidemiology of human African trypanosomiasis","volume":"6","author":"Franco","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ejmech.2021.113861_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2334-8-16","article-title":"Estimates of the duration of the early and late stage of gambiense sleeping sickness","volume":"8","author":"Checchi","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113861_bib7","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human african trypanosomiasis","volume":"390","author":"B\u00fcscher","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113861_bib8","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1371\/journal.pntd.0006890","article-title":"Monitoring the elimination of human African trypanosomiasis: update to 2016","volume":"12","author":"Franco","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113861_bib9","series-title":"Human African Trypanosomiasis and Leishmaniasis","year":"2012"},{"key":"10.1016\/j.ejmech.2021.113861_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1756-3305-5-157","article-title":"Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan","volume":"5","author":"Checchi","year":"2012","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2021.113861_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1371\/journal.pntd.0000333","article-title":"The burden of human african trypanosomiasis","volume":"2","author":"F\u00e8vre","year":"2008","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113861_bib12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-3156.2005.01470.x","article-title":"Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases","volume":"10","author":"Odiit","year":"2005","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ejmech.2021.113861_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/1756-3305-1-3","article-title":"The history of African trypanosomiasis","volume":"1","author":"Steverding","year":"2008","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2021.113861_bib14","first-page":"748","article-title":"The journey towards elimination of gambiense human African trypanosomiasis: not far","volume":"141","author":"Franco","year":"2014","journal-title":"nor easy"},{"key":"10.1016\/j.ejmech.2021.113861_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","article-title":"Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)","volume":"12","author":"Kennedy","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2021.113861_bib16","series-title":"Neglected Trop. Dis. - Sub-saharan Africa","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-3-319-25471-5_4","article-title":"Human african trypanosomiasis (HAT)","author":"Lutumba","year":"2016"},{"key":"10.1016\/j.ejmech.2021.113861_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1179\/2047773213Y.0000000105","article-title":"A\u00a0current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis","volume":"107","author":"Babokhov","year":"2013","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.ejmech.2021.113861_bib18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.pt.2018.08.006","article-title":"The long wait for a new drug for human african trypanosomiasis","volume":"34","author":"Baker","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2021.113861_bib19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/156802611795429167","article-title":"State of the art in african trypanosome drug discovery","volume":"11","author":"Jacobs","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI200421052","article-title":"Human African trypanosomiasis of the CNS: current issues and challenges","volume":"113","author":"Kennedy","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2021.113861_bib21","first-page":"411","article-title":"Human African trypanosomiasis\u2013neurological aspects","volume":"253","author":"Kennedy","year":"2006","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ejmech.2021.113861_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113861_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","article-title":"Melarsoprol resistance in african trypanosomiasis","volume":"34","author":"Fairlamb","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2021.113861_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/mutage\/ges015","article-title":"Genotoxicity profile of fexinidazole-a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)","volume":"27","author":"Tweats","year":"2012","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ejmech.2021.113861_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis","volume":"5","author":"Jacobs","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113861_bib26","series-title":"R&D Portfolio in Review: Sleeping Sickness","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113861_bib27","series-title":"Fexinidazole in Human African Trypanosomiasis Due to T.B. Gambiense at Any Stage","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113861_bib28","series-title":"WHO Interim Guidelines for the Treatment of Gambiense Human African Trypanosomiasis","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113861_bib29","series-title":"Efficacy and Safety of Fexinidazole in Patients with Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei Rhodesiense","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113861_bib30","series-title":"Prospective Study on Efficacy and Safety of Acoziborole (SCYX-7158) in Patients Infected by Human African Trypanosomiasis Due to T.B. Gambiense","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113861_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/0929867324666170120160034","article-title":"A\u00a0brief review of drug discovery research for human african trypanosomiasis","volume":"24","author":"Cullen","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib32","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1371\/journal.pntd.0001734","article-title":"Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human african trypanosomiasis (pharmarcology of new HAT drug (DB844) in monkeys)","volume":"6","author":"Thuita","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113861_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejmech.2013.06.033","article-title":"Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives","volume":"67","author":"Patrick","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib34","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ejmech.2011.01.071","article-title":"1-Aryl-4-nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis","volume":"46","author":"Trunz","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejmech.2015.08.042","article-title":"3-Nitrotriazole-based piperazides as potent antitrypanosomal agents","volume":"103","author":"Papadopoulou","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071753","article-title":"Synthesis and biological activity of Sterol 14\u03b1-demethylase and Sterol C24-methyltransferase inhibitors","volume":"23","author":"Leaver","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113861_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pharmthera.2017.06.004","article-title":"Targeting cysteine proteases in trypanosomatid disease drug discovery","volume":"180","author":"Ferreira","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113861_bib38","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2174\/1389557515666160509125243","article-title":"The inhibition of cysteine proteases Rhodesain and TbCatB: a valuable approach to treat human african trypanosomiasis","volume":"16","author":"Ettari","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib39","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1016\/j.bmc.2019.06.027","article-title":"Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors","volume":"27","author":"de Heuvel","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib40","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1021\/jm200312v","article-title":"Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography","volume":"54","author":"Patterson","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejmech.2015.10.007","article-title":"Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity","volume":"105","author":"Di Pietro","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib42","doi-asserted-by":"crossref","first-page":"10617","DOI":"10.1021\/acs.jmedchem.9b00908","article-title":"Optimization strategy of novel peptide-based Michael acceptors for the treatment of human african trypanosomiasis","volume":"62","author":"Ettari","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib43","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.1021\/jm500239b","article-title":"The design and synthesis of potent and selective inhibitors of Trypanosoma brucei glycogen synthase kinase 3 for the treatment of human african trypanosomiasis","volume":"57","author":"Urich","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib44","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/cmdc.201500204","article-title":"Dipeptidyl enoates as potent Rhodesain inhibitors that display a dual mode of action","volume":"10","author":"Royo","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113861_bib45","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cmdc.200900097","article-title":"Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis","volume":"4","author":"Richardson","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113861_bib46","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1021\/jm301424d","article-title":"Inhibition of Rhodesain as a novel therapeutic modality for human african trypanosomiasis","volume":"56","author":"Ettari","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2015.11.043","article-title":"Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes","volume":"108","author":"Bhambra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib48","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1021\/acs.jmedchem.5b00596","article-title":"Discovery of Indoline-2-carboxamide derivatives as a new class of brain-penetrant inhibitors of trypanosoma brucei","volume":"58","author":"Cleghorn","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib49","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1021\/acs.jmedchem.0c01017","article-title":"Medicinal chemistry optimization of a diaminopurine chemotype: toward a lead for trypanosoma brucei inhibitors","volume":"63","author":"Singh","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib50","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1016\/j.bmc.2018.06.033","article-title":"Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents","volume":"26","author":"Cogo","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib51","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1128\/AAC.01757-15","article-title":"Quinolone amides as antitrypanosomal lead compounds with in\u00a0Vivo activity","volume":"60","author":"Hiltensperger","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113861_bib52","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/jm101439s","article-title":"Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei","volume":"55","author":"Hiltensperger","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib53","series-title":"Preparation of Cyanotriazole Compounds for the Treatment of Leishmaniasis, African Trypanosomiasis and Chagas Disease","author":"Jiricek","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113861_bib54","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1021\/jm400349k","article-title":"Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis","volume":"56","author":"Patel","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib55","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.bmc.2016.04.006","article-title":"Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense","volume":"24","author":"Patrick","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0002012","article-title":"Naphthoquinone derivatives exert their antitrypanosomal activity via a multi-target mechanism","volume":"7","author":"Pieretti","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113861_bib57","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1021\/acs.jmedchem.5b00438","article-title":"6-Arylpyrazine-2-carboxamides: a new core for Trypanosoma brucei inhibitors","volume":"58","author":"Rahmani","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/s-0031-1298241","article-title":"Cynaropicrin: the first plant natural product with in\u00a0vivo activity against trypanosoma brucei","volume":"78","author":"Zimmermann","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2021.113861_bib59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1383-5769(03)00012-6","article-title":"The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice","volume":"52","author":"Yabu","year":"2003","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2021.113861_bib60","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1021\/jm401530a","article-title":"Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for african trypanosomiasis","volume":"56","author":"Vodnala","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/AAC.01263-13","article-title":"Silico prediction and experimental evaluation of furanoheliangolide sesquiterpene lactones as potent agents against trypanosoma brucei rhodesiense","volume":"58","author":"Schmidt","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113861_bib62","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ecoenv.2018.03.032","article-title":"Identification of highly effective antitrypanosomal compounds in essential oils from the Apiaceae family","volume":"156","author":"Ngahang Kamte","year":"2018","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ejmech.2021.113861_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22071129","article-title":"Steroid alkaloids from holarrhena africana with strong activity against trypanosoma brucei rhodesiense","volume":"22","author":"Nnadi","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113861_bib64","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1002\/slct.201601059","article-title":"Scoping studies into the structure-activity relationship (SAR) of phenylephrine-derived analogues as inhibitors of trypanosoma brucei rhodesiense","volume":"1","author":"Cullen","year":"2016","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2021.113861_bib65","first-page":"2","article-title":"Stereochemistry and antiparasitic activity of derivatives of (4R)-4,6-dihydroxy-N-methyl-1,2,3,4-tetrahydroisoquinoline","author":"Cullen","year":"2017","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2021.113861_bib66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/jo00864a030","article-title":"\u03b2-Phenethylamine and tetrahydroisoquinoline alkaloids from the Mexican cactus dolichothele longimamma","volume":"41","author":"Ranieri","year":"1976","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib67","series-title":"Marvin Partitioning Plugin Was Used for LogD Calculations, Marvin 16.4.4.0","year":"2016"},{"key":"10.1016\/j.ejmech.2021.113861_bib68","series-title":"Marvin Partitioning Plugin Was Used for LogD Calculations, Marvin 20.11.0","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113861_bib69","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1246\/bcsj.40.2380","article-title":"Preparation of esters of carboxylic and phosphoric acid via quaternary phosphonium salts","volume":"40","author":"Mitsunobu","year":"1967","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2021.113861_bib70","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1246\/bcsj.40.935","article-title":"Preparation of esters of phosphoric acid by the reaction of trivalent phosphorus compounds with diethyl azodicarboxylate in the presence of alcohols","volume":"40","author":"Mitsunobu","year":"1967","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2021.113861_bib71","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1080\/00397919008053136","article-title":"(p-Dimethylaminophenyl) diphenylphosphine: a more practical phosphine in the Mitsunobu reaction","volume":"20","author":"Von Itzstein","year":"1990","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2021.113861_bib72","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1021\/ja990324r","article-title":"Novel electron-rich bulky phosphine ligands facilitate the palladium- catalyzed preparation of diaryl ethers","volume":"121","author":"Aranyos","year":"1999","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113861_bib73","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1071\/CH9791317","article-title":"Synthesis and biological evaluation of tetrahydroisoquinolin-4-ol derivatives","volume":"32","author":"Quessy","year":"1979","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib74","series-title":"Tetrahydronaphthyl- Piperazines as 5-ht1b Antagonists, Inverse Agonists and Partial Agonists","author":"Brodney","year":"2005"},{"key":"10.1016\/j.ejmech.2021.113861_bib75","series-title":"Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability","author":"Van de Waterbeemd","year":"2009"},{"key":"10.1016\/j.ejmech.2021.113861_bib76","series-title":"Drug-like Properties: Concepts, Structure Design and Methods : from ADME to Toxicity Optimization","author":"Kerns","year":"2008"},{"key":"10.1016\/j.ejmech.2021.113861_bib77","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.chemosphere.2008.04.074","article-title":"Lipophilicity for ionisable compounds","volume":"72","author":"Kah","year":"2008","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejmech.2021.113861_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2021.113861_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113861_bib80","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of Pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib81","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113861_bib82","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A\u00a0BOILED-egg to predict Gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113861_bib83","series-title":"Purification of Laboratory Chemicals","author":"Armarego","year":"2009"},{"key":"10.1016\/j.ejmech.2021.113861_bib84","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/AAC.01508-05","article-title":"New azasterols against trypanosoma brucei: role of 24-sterol methyltransferase in inhibitor action","volume":"50","author":"Gros","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113861_bib85","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2021.113861_bib86","first-page":"67","article-title":"R\u00e9actions de cyclisation ph\u00e9nolique entre quelques (hydroxy-3 et dihydroxy-3,4 ph\u00e9nyl)-1amino-2 \u00e9thanols et l\u2019acide glyoxylique ou ses esters","volume":"4","author":"Fourneau","year":"1969","journal-title":"Chim. Th\u00e9rapeutique."},{"key":"10.1016\/j.ejmech.2021.113861_bib87","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1021\/ol3017676","article-title":"{1,6}-Transannular catalytic asymmetric Gosteli\u2013claisen rearrangement","volume":"14","author":"Jaschinski","year":"2012","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113861_bib88","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/jo00005a018","article-title":"Rearrangement of 1,3-diradicals. Arylcyclopropane photochemistry","volume":"56","author":"Zimmerman","year":"1991","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib89","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1021\/jo00362a044","article-title":"The tosylation of alcohols","volume":"51","author":"Kabalka","year":"1986","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib90","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejmech.2008.03.011","article-title":"Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site","volume":"44","author":"Zampieri","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113861_bib91","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1021\/jm0201518","article-title":"Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi","volume":"45","author":"Elhalem","year":"2002","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:36:50Z","timestamp":1759329410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421007108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":91,"alternative-id":["S0223523421007108"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113861","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of tetrahydroisoquinoline derivatives against Trypanosoma brucei rhodesiense","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113861"}}